<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P02667259A0331 There were 3/32 (9.4 per cent) adverse reactions (ADRs), and one case each of nausea, dizziness and increased menstrual flow."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="140" language="x-unspecified"/></CAS>